93 related articles for article (PubMed ID: 17965955)
21. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
Sheng X; Guo Y; Lu Y
Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
[TBL] [Abstract][Full Text] [Related]
22. Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
Sailer V; Gevensleben H; Dietrich J; Goltz D; Kristiansen G; Bootz F; Dietrich D
PLoS One; 2017; 12(6):e0179412. PubMed ID: 28617833
[TBL] [Abstract][Full Text] [Related]
23.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
24. Tumour biomarkers: homeostasis as a novel prognostic indicator.
Falco M; Palma G; Rea D; De Biase D; Scala S; D'Aiuto M; Facchini G; Perdonà S; Barbieri A; Arra C
Open Biol; 2016 Dec; 6(12):. PubMed ID: 27927793
[TBL] [Abstract][Full Text] [Related]
25. DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract.
Uhl B; Dietrich D; Branchi V; Semaan A; Schaefer P; Gevensleben H; Rostamzadeh B; Lingohr P; Schäfer N; Kalff JC; Kristiansen G; Matthaei H
PLoS One; 2016; 11(10):e0165769. PubMed ID: 27798672
[TBL] [Abstract][Full Text] [Related]
26. Methylation in promoter regions of PITX2 and RASSF1A genes in association with clinicopathological features in breast cancer patients.
Jezkova E; Kajo K; Zubor P; Grendar M; Malicherova B; Mendelova A; Dokus K; Lasabova Z; Plank L; Danko J
Tumour Biol; 2016 Oct; ():. PubMed ID: 27744628
[TBL] [Abstract][Full Text] [Related]
27. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
[TBL] [Abstract][Full Text] [Related]
28.
Holmes EE; Goltz D; Sailer V; Jung M; Meller S; Uhl B; Dietrich J; Röhler M; Ellinger J; Kristiansen G; Dietrich D
Clin Epigenetics; 2016; 8():104. PubMed ID: 27708722
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.
Terry MB; McDonald JA; Wu HC; Eng S; Santella RM
Adv Exp Med Biol; 2016; 882():33-68. PubMed ID: 26987530
[TBL] [Abstract][Full Text] [Related]
30. Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer.
Wang Q; Li J; Wu W; Shen R; Jiang H; Qian Y; Tang Y; Bai T; Wu S; Wei L; Zang Y; Zhang J; Wang L
Oncotarget; 2016 Mar; 7(10):11208-22. PubMed ID: 26848620
[TBL] [Abstract][Full Text] [Related]
31. Paired-like Homeodomain Transcription factor 2 expression by breast cancer bone marrow disseminated tumor cells is associated with early recurrent disease development.
Pillai SG; Dasgupta N; Siddappa CM; Watson MA; Fleming T; Trinkaus K; Aft R
Breast Cancer Res Treat; 2015 Oct; 153(3):507-17. PubMed ID: 26400846
[TBL] [Abstract][Full Text] [Related]
32. Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential.
Cava C; Bertoli G; Castiglioni I
BMC Syst Biol; 2015 Sep; 9():62. PubMed ID: 26391647
[TBL] [Abstract][Full Text] [Related]
33. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
34. Identification of the GTPase-activating protein DEP domain containing 1B (DEPDC1B) as a transcriptional target of Pitx2.
Wu D; Zhu X; Jimenez-Cowell K; Mold AJ; Sollecito CC; Lombana N; Jiao M; Wei Q
Exp Cell Res; 2015 Apr; 333(1):80-92. PubMed ID: 25704760
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation biomarkers: cancer and beyond.
Mikeska T; Craig JM
Genes (Basel); 2014 Sep; 5(3):821-64. PubMed ID: 25229548
[TBL] [Abstract][Full Text] [Related]
36. FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway.
Basu M; Mukhopadhyay S; Chatterjee U; Roy SS
J Biol Chem; 2014 Jan; 289(3):1415-28. PubMed ID: 24253043
[TBL] [Abstract][Full Text] [Related]
37. PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer.
Vela I; Morrissey C; Zhang X; Chen S; Corey E; Strutton GM; Nelson CC; Nicol DL; Clements JA; Gardiner EM
Clin Exp Metastasis; 2014 Feb; 31(2):199-211. PubMed ID: 24162257
[TBL] [Abstract][Full Text] [Related]
38. Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition.
Dietrich D; Uhl B; Sailer V; Holmes EE; Jung M; Meller S; Kristiansen G
PLoS One; 2013; 8(10):e77771. PubMed ID: 24155973
[TBL] [Abstract][Full Text] [Related]
39. Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomy.
Dietrich D; Hasinger O; Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Wernert N; Perner S; Freedland SJ; Corman JM; Ittmann MM; Lark AL; Madden JF; Hartmann A; Schatz P; Kristiansen G
J Mol Diagn; 2013 Mar; 15(2):270-9. PubMed ID: 23266319
[TBL] [Abstract][Full Text] [Related]
40. Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.
Basu M; Roy SS
J Biol Chem; 2013 Feb; 288(6):4355-67. PubMed ID: 23250740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
